BASEL, Switzerland, July 17, 2003 (PRIMEZONE) -- Roche:
23 July 2003, 7 CET -- release will be e-mailed and posted on the Roche IR website. Presentation slides and the Half Year Report 2003 will be posted on the Roche IR website http://ir.roche.com.
8.00 CET-- Conference call will commence with presentations by senior management followed by a Q&A session. Participants will be:
Dr. Erich Hunziker, Chief Financial Officer, William M. Burns, Head of the Pharmaceuticals Division and Heino von Prondzynski, Head of the Diagnostics Division Dr. Karl Mahler, Head of Investor Relations
Analysts are invited to dial in to the conference using the following dial-in numbers:
+41 91 610 5600 (Europe and ROW) or +44 207 107 06 11 (UK) or +1 866 291 41 66 (USA).
Please dial into the conference call 10-15 minutes before the call is scheduled to start. You are also invited to download the presentation from the website. Alternatively you can follow the conference as a Live Audio Webcast through the Internet site http://ir.roche.com.
A replay of the conference call will be available one hour after the conference call, for 48 hours. Access is by dialing: +41 91 612 4330 (Europe) or +44 207 866 4300 (UK) and +1 412 858 1440 (USA) and enter the conference ID 400 followed by the # sign. A replay of the webcast will be available on demand at http://ir.roche.com.
Zurich, 23 July 2003, 14.30 CET -- General Presentation and Q & A session will be held by:
Dr. Franz B. Humer, Chief Executive Officer Dr. Erich Hunziker, Chief Financial Officer William M. Burns, Head of the Pharmaceuticals Division and Heino von Prondzynski, Head of the Diagnostics Division
Following the general presentation will be four break-out sessions covering the topics Strategy & Finance, Pharmaceuticals, Diagnostics and Accounting. The break-out sessions will be recorded and placed on the web within 48 hours.
For those who cannot attend in person, the presentation and Q&A session can be listened to via a telephone link (listen only mode, no live access to speakers). Please dial into the call 10-15 minutes before is scheduled to start. The Dial in numbers are:
+41 91 610 5600 (Europe and ROW) or +44 207 107 06 11 (UK) or +1 412 858 4600 (USA).
You are also invited to download the presentation from the website. In addition, a Live Audio Webcast of the conference call will be available on our website http://ir.roche.com.
A replay of the conference call will be available one hour after the event, for 48 hours. Access is by dialing: +41 91 612 4330 (Europe) or +44 207 866 4300 (UK) and +1 412 858 1440 (USA) and enter the Conference ID 514 followed by the # sign. A replay of the webcast will be available on demand at http://ir.roche.com.
New York, 24 July 2003, 14.15 New York EDT (Eastern Daylight Time) / 20.15 CET -- General Presentation and Q & A will be held by:
Dr. Franz B. Humer, Chief Executive Officer Dr. Erich Hunziker, Chief Financial Officer William M. Burns, Head of the Pharmaceuticals Division and Heino von Prondzynski, Head of the Diagnostics Division
Following the general presentation will be four break-out sessions covering the topics Strategy & Finance, Pharmaceuticals, Diagnostics and Accounting. The break-out sessions will be recorded and placed on the web within 48 hours.
For those who cannot attend in person, the presentation and Q&A session can be listened to via a telephone link (listen only mode, no live access to speakers). Please dial into the call 10-15 minutes before is scheduled to start. The Dial in numbers are:
+41 91 610 5600 (Europe and ROW) or +44 207 107 06 11 (UK) or +1 412 858 4600 (USA).
You are also invited to download the presentation from the website. In addition, a Live Audio Webcast of the conference call will be available on our website http://ir.roche.com.
A replay of the conference call will be available one hour after the event, for 48 hours. Access is by dialing: +41 91 612 4330 (Europe) or +44 207 866 4300 (UK) and +1 412 858 1440 (USA) and enter the Conference ID 682 followed by the # sign. A replay of the webcast will be available on demand at http://ir.roche.com